Last 12 months
Inside the activity.
13 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 3 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 5 | 3 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2024 Filed Jun 12, 2024 20:11 UTC |
Mitchell MicahChief Commercial Officer
|
Tax withholdingCommon Stock | 6,837 | $3.38 | $23,088.55 |
DisclosureSEC source: 0000950170-24-072449 · ownership.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,598 F1 · shares: Shares sold solely to pay income taxes resulting from the vesting of multiple restricted stock unit grants on June 8 and June 9, 2024, pursuant to an irrevocable election made by the Reporting Party on May 10, 2024. F2 · price: Represents the average selling price. Shares were sold in multiple lots at prices ranging from $3.33 to $3.39 per share. The Reporting Party agrees to provide detials of the transactions to the SEC upon request. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 20:14 UTC |
HENRY DAVID AChief Financial Officer
|
Tax withholdingCommon Stock | 10,620 | $3.38 | $35,853.12 |
DisclosureSEC source: 0000950170-24-072455 · ownership.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 403,799 F1 · shares: Shares sold solely to pay income taxes resulting from the vesting of multiple restricted stock unit grants on June 8 and June 9, 2024, pursuant to an irrevocable election made by the Reporting Party on May 10, 2024. F2 · price: Represents the average selling price. Shares were sold in multiple lots at prices ranging from $3.33 to $3.39 per share. The Reporting Party agrees to provide detials of the transactions to the SEC upon request. Read SEC document |
| June 10, 2024 Filed Jul 3, 2024 00:28 UTC Amendment |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 5,347 | $3.38 | $18,067.51 |
DisclosureSEC source: 0000950170-24-081005 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,541 F2 · shares: Shares sold solely to pay income taxes resulting from the vesting of multiple restricted stock unit grants on June 8 and June 9, 2024, pursuant to an irrevocable election made by the Reporting Party on May 12, 2024. F3 · price: Represents the average selling price. Shares were sold in multiple lots at prices ranging from $3.33 to $3.39 per share. The Reporting Party agrees to provide detials of the transactions to the SEC upon request. F1 · acquired: This amendment corrects the coding of this transaction from an acquisition in the original filing on June 12, 2024 to a disposition. No other changes to this Form. Read SEC document |
| June 10, 2024 Filed Jul 3, 2024 00:36 UTC Amendment |
Mitchell MicahChief Commercial Officer
|
Tax withholdingCommon Stock | 6,837 | $3.38 | $23,088.55 |
DisclosureSEC source: 0000950170-24-081017 · ownership.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,598 F2 · shares: Shares sold solely to pay income taxes resulting from the vesting of multiple restricted stock unit grants on June 8 and June 9, 2024, pursuant to an irrevocable election made by the Reporting Party on May 10, 2024. F3 · price: Represents the average selling price. Shares were sold in multiple lots at prices ranging from $3.33 to $3.39 per share. The Reporting Party agrees to provide detials of the transactions to the SEC upon request. F1 · acquired: This amendment corrects the coding of this transaction from an acquisition in the original filing on June 12, 2024 to a disposition. No other changes to this Form Read SEC document |
| June 09, 2024 Filed Jan 24, 2025 21:58 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 6,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-008859 · ownership.xml · derivative · entry 2 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,024 shares Expires 2024-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.underlying_shares: Represents performance-based restricted stock units granted under the Issuer's 2018 Stock Option and Incentive Plan. 6,024 shares were earned based on the Company's relative stock price performance from June 10, 2021 to March 9, 2024 against a peer group of companeis, which are reported in Table I of this report on Form 4. The remaining 33,976 restricted stock units granted expired unvested. Read SEC document |
| June 09, 2024 Filed Jan 24, 2025 21:58 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 6,024 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-008859 · ownership.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,014,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of performance-based restricted stock units granted under the Issuer's 2018 Stock Option and Incentive plan based on the relative stock price performance of the Company's common stock compared to a peer group of companies as measured from June 10, 2021 to March 9, 2024. Read SEC document |
| June 09, 2024 Filed Jan 24, 2025 22:02 UTC |
Kovelman HarryChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,235 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-008872 · ownership.xml · derivative · entry 2 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,235 shares Expires 2024-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.underlying_shares: Represents performance-based restricted stock units granted under the Issuer's 2018 Stock Option and Incentive Plan. 1,235 shares were earned based on the Company's relative stock price performance from June 10, 2021 to March 9, 2024 compared to a peer group of companies, which are reported in Table I of this report on Form 4. The remaining 6,965 restricted stock units granted expired unvested. Read SEC document |
| June 09, 2024 Filed Jan 24, 2025 22:02 UTC |
Kovelman HarryChief Medical Officer
|
Exercise / conversionCommon Stock | 1,235 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-008872 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of performance-based restricted stock units granted under the Issuer's 2018 Stock Option and Incentive plan based on the relative stock price performance of the Company's common stock compared to a peer group of companies as measured from June 10, 2021 to March 9, 2024. Read SEC document |
| June 09, 2024 Filed Jan 24, 2025 22:09 UTC |
Mitchell MicahChief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,717 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-008883 · ownership.xml · derivative · entry 2 Mitchell Micah · CIK 0001746072 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,717 shares Expires 2024-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.underlying_shares: Represents performance-based restricted stock units granted under the Issuer's 2018 Stock Option and Incentive Plan. 1,717 shares were earned based on the Company's relative stock price performance compared to a peer group of companies from June 10, 2021 to March 9, 2024, which are reported in Table I of this report on Form 4. The remaining 9,683 restricted stock units granted expired unvested. Read SEC document |
| June 09, 2024 Filed Jan 24, 2025 22:09 UTC |
Mitchell MicahChief Commercial Officer
|
Exercise / conversionCommon Stock | 1,717 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-008883 · ownership.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,815 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of performance-based restricted stock units granted under the Issuer's 2018 Stock Option and Incentive plan based on the relative stock price performance of the Company's common stock compared to a peer group of companies as measured from June 10, 2021 to March 9, 2024. Read SEC document |
| June 09, 2024 Filed Jan 24, 2025 22:05 UTC |
HENRY DAVID AChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,012 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-008877 · ownership.xml · derivative · entry 2 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,012 shares Expires 2024-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.underlying_shares: Represents performance-based restricted stock units granted under the Issuer's 2018 Stock Option and Incentive Plan. 3,012 shares were earned based on the Company's relative stock price performance from June 10, 2021 to March 9, 2024 compared to a peer group of companies, which are reported in Table I of this report on Form 4. The remaining 16,998 restricted stock units granted expired unvested. Read SEC document |
| June 09, 2024 Filed Jan 24, 2025 22:05 UTC |
HENRY DAVID AChief Financial Officer
|
Exercise / conversionCommon Stock | 3,012 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-008877 · ownership.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 381,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of performance-based restricted stock units granted under the Issuer's 2018 Stock Option and Incentive plan based on the relative stock price performance of the Company's common stock compared to a peer group of companies as measured from June 10, 2021 to March 9, 2024. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:43 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
GrantCommon Stock | 130,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-070771 · ownership.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 959,845 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in annual installments over three years beginning on June 5, 2025. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:47 UTC |
Kovelman HarryChief Medical Officer
|
GrantCommon Stock | 53,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-070787 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,888 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in annual installments over three years beginning on June 5, 2025. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:49 UTC |
Mitchell MicahChief Commercial Officer
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-070801 · ownership.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,435 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in annual installments over three years beginning on June 5, 2025. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 16:07 UTC |
Knapp Amy K.Director
|
GrantCommon Stock | 12,034 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-070615 · ownership.xml · nonDerivative · entry 1 Knapp Amy K. · CIK 0001707416 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,645 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in quarterly installments over one year beginning on September 7, 2024. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:27 UTC |
Getz Heather CDirector
|
GrantCommon Stock | 12,034 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-070689 · ownership.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,034 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in quarterly installments over one year beginning on September 7, 2024. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:34 UTC |
Morris Milton MayoDirector
|
GrantCommon Stock | 12,034 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-070737 · ownership.xml · nonDerivative · entry 1 Morris Milton Mayo · CIK 0001454309 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,967 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in quarterly installments over one year beginning on September 7, 2024. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:39 UTC |
KIRK THOMAS FDirector
|
GrantCommon Stock | 12,034 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-070753 · ownership.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 248,533 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in quarterly installments over one year beginning on September 5, 2024. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:53 UTC |
HENRY DAVID AChief Financial Officer
|
GrantCommon Stock | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-070818 · ownership.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 414,419 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in annual installments over three years beginning on June 5, 2025. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:30 UTC |
Crowley Thomas Aloysius Jr.Director
|
GrantCommon Stock | 12,034 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-070721 · ownership.xml · nonDerivative · entry 1 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,028 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in quarterly installments over one year beginning on September 7, 2024. Read SEC document |
| June 05, 2024 Filed Jan 22, 2025 21:21 UTC Amendment |
GUDONIS PAUL RDirector · Chief Executive Officer
|
GrantCommon Stock | 130,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-007772 · ownership.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,008,245 F2 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in annual installments over three years beginning on June 5, 2025. F1 · balance_after: This amendment corrects the number of shares held by the Reporting Person after this transaction. No other changes to this Form 4. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 21:52 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 121 | $3.48 | $421.08 |
DisclosureSEC source: 0000950170-24-069474 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,888 F1 · price: Represents shares sold on June 3, 2024 solely to cover income taxes resulting from the vesting of restricted stock units on June 2, 2024. Transaction was completed pursuant to an irrevocable election made by the Reporting Party in conjunction with the original grant in November 2020. Read SEC document |
| May 29, 2024 Filed May 31, 2024 21:43 UTC |
KIRK THOMAS FDirector
|
PurchaseCommon Stock | 50,000 | $3.50 | $175,000.00 |
DisclosureSEC source: 0000950170-24-067480 · ownership.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,499 F1 · price: Shares were purchased in multiple lots at $3.50 per share in open market transactions. Reporting party agrees to furnish details of the transactions to the SEC upon request. Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:57 UTC |
Kovelman HarryChief Medical Officer
|
SaleCommon Stock | 35,426 | $3.69 | $130,838.85 |
DisclosureSEC source: 0000950170-24-061827 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,009 F1 · price: Represents average sales price. Sales were transacted in multiple lots at prices ranging from $3.60 to $3.76 per share. Reporting Party agrees to provide detials of the trades to the SEC upon request. Read SEC document |
| May 03, 2024 Filed May 6, 2024 21:10 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 146 | $3.84 | $560.64 |
DisclosureSEC source: 0000950170-24-053682 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,435 F1 · shares: Represents shares sold on May 3, 2024 solely to pay income taxes resulting from the vesting of restricted stock units on May 2, 2024. Transaction was completed pursuant to an irrevocable election made by the Reporting Party in conjunction with the original grant in November 2020. Read SEC document |
| April 03, 2024 Filed Apr 4, 2024 21:50 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 146 | $2.97 | $433.62 |
DisclosureSEC source: 0000950170-24-041921 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,581 F1 · shares: Represents shares sold on April 3, 2024 solely to pay income taxes resulting from the vesting of restricted stock units on April 2, 2024. Transaction was completed pursuant to an irrevocable election made by the Reporting Party in conjunction with the original grant in November 2020. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 11:48 UTC |
KIRK THOMAS FDirector
|
PurchaseCommon Stock | 50,000 | $3.50 | $175,000.00 |
DisclosureSEC source: 0000950170-24-032523 · ownership.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,499 F1 · price: Shares were purchased in multiple lots at $3.50 per share in open market transactions. Reporting party agrees to furnish details of the transactions to the SEC upon request. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:32 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 6,590 | $3.51 | $23,130.90 |
DisclosureSEC source: 0000950170-24-030821 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,727 F1 · shares: Represents shares sold on March 11, 2024 solely to pay income taxes resulting from the vesting of restricted stock units on March 8, 2024. Transaction was completed pursuant to an irrevocable election made by the Reporting Party on March 8, 2024. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:31 UTC |
Mitchell MicahChief Commercial Officer
|
Tax withholdingCommon Stock | 5,359 | $3.51 | $18,810.09 |
DisclosureSEC source: 0000950170-24-030820 · ownership.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 156,435 F1 · shares: Represents shares sold on March 11, 2024 solely to pay income taxes resulting from the vesting of restricted stock units on March 8, 2024. Transaction was completed pursuant to an irrevocable election made by the Reporting Party on March 8, 2024. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:33 UTC |
HENRY DAVID AChief Financial Officer
|
Tax withholdingCommon Stock | 7,774 | $3.51 | $27,286.74 |
DisclosureSEC source: 0000950170-24-030822 · ownership.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 344,419 F1 · shares: Represents shares sold on March 11, 2024 solely to pay income taxes resulting from the vesting of restricted stock units on March 8, 2024. Transaction was completed pursuant to an irrevocable election made by the Reporting Party on March 8, 2024. Read SEC document |
| March 11, 2024 Filed Mar 13, 2025 20:33 UTC |
Mitchell MicahChief Commercial Officer
|
GrantCommon Stock | 3,737 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-038808 · ownership.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,855 F1 · shares: Represents a grant of restricted stock units ("RSU's) on March 11, 2025 under the Issuer's 2018 Stock Option and Incentive Plan. The RSU's immediately vested on the grant date. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 12:21 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 147 | $3.88 | $570.36 |
DisclosureSEC source: 0000950170-24-026872 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,317 F1 · shares: Represents shares sold on March 5, 2024 solely to pay income taxes on the vesting of restricted stock units on March 2, 2024. Transaction was completed pursuant to an irrevocable election made by the Reporting Party in conjunction with the original grant in November 2020. Read SEC document |
| February 05, 2024 Filed Feb 5, 2024 23:34 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 146 | $3.21 | $468.66 |
DisclosureSEC source: 0000950170-24-011407 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,464 F1 · shares: Represents shares sold on February 5, 2024 solely to pay income taxes on the vesting of restricted stock units on February 2, 2024. Transaction was completed pursuant to an irrevocable election made by the Reporting Party in conjunction with the original grant in November 2020. Read SEC document |
| January 19, 2024 Filed Jan 22, 2024 22:06 UTC |
Morris Milton MayoDirector
|
GrantCommon Stock | 25,000 | $3.80 | $95,000.00 |
DisclosureSEC source: 0000950170-24-006122 · ownership.xml · nonDerivative · entry 1 Morris Milton Mayo · CIK 0001454309 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,933 F1 · shares: Shares were purchased by the Reporting Party in conjunction with a Registered Direct offering by the Registrant under Rule 16-3, which closed on Janaury 19, 2024. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 23:03 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 145 | $4.69 | $680.05 |
DisclosureSEC source: 0000950170-24-002078 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,610 F1 · shares: Represents shares sold on January 3, 2024 solely to pay income taxes resulting from the vesting of restricted stock units on January 2, 2024. Transaction was completed pursuant to an irrevocable election made by the Reporting Party in conjunction with the original grant in November 2020. Read SEC document |
| December 08, 2023 Filed Dec 9, 2023 00:50 UTC |
Crowley Thomas Aloysius Jr.Director
|
SaleCommon Stock | 14,997 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-069146 · ownership.xml · nonDerivative · entry 1 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,994 F1 · shares: Shares were sold pursuant to a domestic relations agreement entered into by the Reporting Party. F2 · price: Transactions were made in multiple lots at sale prices ranging from $4.08 per share to $4.37 per share. Reporting person agrees to provide details of the transactions to a Myomo security holder or the SEC upon request. Read SEC document |
| December 05, 2023 Filed Dec 5, 2023 22:56 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 99 | $4.02 | $397.98 |
DisclosureSEC source: 0000950170-23-068302 · ownership.xml · nonDerivative · entry 2 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,755 F2 · shares: Represents shares sold on December 5, 2023 solely to pay income taxes resulting from the vesting of restricted stock units on December 2, 2023. Transaction was completed pursusnt to an irrevocable election made by the Reporting Person in conjunction with the original grant in November 2020. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:56 UTC |
Kovelman HarryChief Medical Officer
|
SaleCommon Stock | 8,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-068302 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,854 F1 · price: Shares sold in multiple lots at sale prices ranging from $3.122 to $3.13 per share. Reporting party agrees to provide details of the transactions to a Myomo shareholder or the SEC upon request. Read SEC document |
| November 28, 2023 Filed Nov 30, 2023 23:00 UTC |
Crowley Thomas Aloysius Jr.Director
|
SaleCommon Stock | 14,997 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-067098 · ownership.xml · nonDerivative · entry 1 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,001 F1 · shares: Shares were sold pursuant to a domestic relations agreement entered into by the Reporting Party. F2 · price: Transactions were made in multiple lots at prices ranging from $3.27 to $3.40 per share. The Reporting Party agrees to provide details of the trades to a Myomo security holder or the SEC upon request. Read SEC document |
| November 20, 2023 Filed Dec 15, 2023 00:46 UTC |
KIRK THOMAS FDirector
|
PurchaseCommon Stock | 50,000 | $3.10 | $155,000.00 |
DisclosureSEC source: 0000950170-23-070531 · ownership.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,499 F1 · price: Shares were purchased in one lot at $3.10 per share in an open market transaction Read SEC document |
| November 06, 2023 Filed Nov 6, 2023 23:42 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 121 | $1.41 | $170.61 |
DisclosureSEC source: 0000950170-23-059604 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 149,187 F1 · shares: Represents shares sold on November 6, 2023 soley to pay income taxes resulting from the vesting of restricted stock units on November 2, 2023. Transaction was completed pursuant to an irrevocable election made by the Reporting Person in conjunction with the original grant in November 2020 Read SEC document |
| October 03, 2023 Filed Oct 3, 2023 21:34 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 123 | $1.10 | $135.30 |
DisclosureSEC source: 0000950170-23-051684 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 149,308 F1 · shares: Represents shares sold on October 3, 2023 solely to pay income taxes resulting from the vesting of restricted stock units on October 2, 2023. Transaction was completed pursuant to an irrevocable election made by the Reporting Person in conjunction with the original grant in November 2020. Read SEC document |
| September 08, 2023 Filed Sep 11, 2023 21:05 UTC |
Morris Milton MayoDirector
|
PurchaseCommon Stock | 15,000 | $1.06 | $15,867.00 |
DisclosureSEC source: 0000950170-23-047520 · ownership.xml · nonDerivative · entry 1 Morris Milton Mayo · CIK 0001454309 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,933 F1 · price: Represents average purchase price. Purchase transactions were made in multiple lots at prices ranging ffrom $0.9779 to $1.14 per share. Reporting person agrees to supply details of the invididual transactions to the Commission upon request. Read SEC document |
| September 05, 2023 Filed Sep 6, 2023 22:47 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 125 | $0.87 | $108.75 |
DisclosureSEC source: 0000950170-23-046821 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 149,431 F1 · shares: Represents shares sold on September 5, 2023 solely to pay income taxes resulting from the vesting of restricted stock units on September 2, 2023. Transaction was completed pursuant to an irrevocable election made by the Reporting Person in conjunction with the original grant in November 2020. Read SEC document |
| August 30, 2023 Filed Aug 31, 2023 22:26 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
PurchaseCommon Stock | 48,400 | $0.74 | $36,038.64 |
DisclosureSEC source: 0000950170-23-045865 · ownership.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 878,245 F1 · price: Represents weighted average purchase price. Purchase transactions were completed in multiple lots at prices ranging $0.707 to $0.7999 per share. Reporting Person agrees to provide details of the transactions to the Commission upon request. Read SEC document |
| August 29, 2023 Filed Aug 30, 2023 20:22 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
PurchaseCommon Stock | 37,000 | $0.78 | $28,797.10 |
DisclosureSEC source: 0000950170-23-045447 · ownership.xml · nonDerivative · entry 2 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 829,845 F2 · price: Represents volume weighted average purchase price. Purchases were made in multiple lots at prices ranging from $0.75 to $0.813 per share. Reporting person agrees to provide details of the transactions to the Commission upon request. Read SEC document |
| August 29, 2023 Filed Aug 30, 2023 21:00 UTC |
Kovelman HarryChief Medical Officer
|
PurchaseCommon Stock | 8,333 | $0.60 | $4,999.80 |
DisclosureSEC source: 0000950170-23-045501 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,556 F1 · shares: Represents purchase of common stock as part of a public offering under Form S-3 by the Registrant, which closed on August 29, 2023 Read SEC document |
| August 29, 2023 Filed Aug 30, 2023 20:36 UTC |
HENRY DAVID AChief Financial Officer
|
PurchaseCommon Stock | 41,666 | $0.60 | $24,999.60 |
DisclosureSEC source: 0000950170-23-045473 · ownership.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 352,193 F1 · shares: Represents purchase of shares as part of a public offering by the Registrant under Form S-3, which closed on August 29, 2023. Read SEC document |
| August 29, 2023 Filed Jan 12, 2024 22:43 UTC Amendment |
Kovelman HarryChief Medical Officer
|
GrantCommon Stock | 8,333 | $0.60 | $4,999.80 |
DisclosureSEC source: 0000950170-24-004311 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,556 F1 · shares: Represents purchase of shares as part of a public offering by the Regsitrant under Form S-3, which closed on August 29, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.